Safety and Efficacy of Combination Therapy of Upadacitinib and Biologic Agents for Treatment-Resistant Psoriasis and Psoriatic Arthritis. (2024). SKIN The Journal of Cutaneous Medicine, 8(3), 1574-1580. https://doi.org/10.25251/skin.8.3.17